483 Sinsin Pharmaceutical Mar 2016

483 Sinsin Pharmaceutical Mar 2016

Luis Dasta FDA$119.00 - Available Now

FDA investigators audited the Sinsin Pharmaceutical - Ansansi Danweon-gu, Korea (the Republic of) facility and issued 9 inspectional observations (via FDA 483) on 11 Mar 2016.

Product details

  • Category: Human Drugs
  • Number of Observations: 9
  • Inspection end: 11 Mar 2016
  • Location: Ansansi Danweon-gu, Korea (the Republic of)
  • FEI: 3002277609
Add To Cart